PlainRecalls
FDA Drug Low Class III Terminated

Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505

Reported: February 27, 2019 Initiated: February 13, 2019 #D-0506-2019

Product Description

Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing

Details

Units Affected
8,159 bottles
Distribution
Throughout the United States
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 8,159 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on February 27, 2019. Severity: Low. Recall number: D-0506-2019.